Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-09 · accession 0001415889-25-016724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Quart Barry D | Dir | M - OptEx | $3.80 | +27.4K | 20.8K | New | +$104.3K |
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Quart Barry D | Dir | S - Sale+OE | $30.35 | -27.4K | 12.5K | -69% | -$833.0K |
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Quart Barry D | Dir | M - OptEx | $0.00 | -27.4K | 12.3K | -69% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-06-09 | M | A | 6,900 | $3.80 | 19,446 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-06-09 | S | D | 6,900 | $30.26 | 12,546 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-06-10 | S | D | 8,212 | $30.36 | 12,546 | D | — | — | (F1) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.00 and $30.52. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2025-06-11 | M | A | 12,336 | $3.80 | 24,882 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-06-11 | S | D | 12,336 | $30.39 | 12,546 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.28 and $30.5801. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2025-06-10 | M | A | 8,212 | $3.80 | 20,758 | D | — | — | |
| 7 | Derivative | Share Option | 2025-06-11 | M | D | 12,336 | $0.00 | 0 | D | $3.80 · — to 2027-06-28 | 12,336 Class A Ordinary Shares | (F3) The option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2025-06-09 | M | D | 6,900 | $0.00 | 20,548 | D | $3.80 · — to 2027-06-28 | 6,900 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2025-06-10 | M | D | 8,212 | $0.00 | 12,336 | D | $3.80 · — to 2027-06-28 | 8,212 Class A Ordinary Shares | (F3) The option is fully vested and exercisable. |